SEC Reports
13
VREOF
Vireo Growth Inc.
$9.61 ▼ -2.44%
Prev close $9.8512-mo target$45.00 (+368.3%)
High Impact Filing (7/10) Biotech & Drug Discovery
Snapshot
The big-picture read on VREOF right now — valuation, ownership and activity at a glance.
Price chart 30d -11.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 3, 2026 ftd
Aug 18, 2026 SEC FTD: VREOF — 69,984 shares ($0.8M) failed to deliver
Settlement: 20260903, Price: $10.80, FTD Value: $755,827.2, VIREO GROWTH INC SUB VTG SHS (
Vireo Growth Inc. announced a Normal Course Issuer Bid (NCIB) authorizing the repurchase of up to 2,426,872 subordinate
8-K — Impact 3/10
Vireo Growth reported Q2 2026 GAAP revenue of $209.3M (+335% YoY), massively beating the $167.4M consensus, but GAAP EPS
8-K — Impact 6/10
Vireo Growth Inc. (VREOF) has entered into two separate Securities Purchase Agreements to acquire all of the membership
8-K — Impact 7/10
May 15, 2026 Insider
Hussey Ross Michael was granted 115,506 shares
Director
May 15, 2026 Insider
Hussey Ross Michael was granted 96,859 shares
Director
May 15, 2026 Insider
Mancebo Victor E. was granted 96,859 shares
Director
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | 0 | 0 | 3 | 4 | 2 | 0% | |
| Aug 1, 2023 | 0 | 0 | 3 | 4 | 2 | 0% | |
| Jul 1, 2023 | 0 | 0 | 3 | 4 | 2 | 0% | |
| Jun 1, 2023 | 0 | 0 | 3 | 4 | 2 | 0% |
Price targets
Where 1 covering analysts think VREOF trades over the next 12 months.
$45.00 +368.3% upside Strong Buy
Current$9.61 Low$45.00 Median$45.00 High$45.00 1 analysts
$45.00$45.00
Analyst rating Strong Buy· 1.0/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
13 SEC filing reports analyzed · 2 bullish, 1 bearish, 5 mixed, 5 neutral · avg impact 5.5/10.
NEUTRAL8-K3/10
Vireo Growth Inc. announced a Normal Course Issuer Bid (NCIB) authorizing the repurchase of up to 2,
Aug 18, 2026
MIXED8-K6/10
Vireo Growth reported Q2 2026 GAAP revenue of $209.3M (+335% YoY), massively beating the $167.4M con
Aug 11, 2026
BULLISH8-K7/10
Vireo Growth Inc. (VREOF) has entered into two separate Securities Purchase Agreements to acquire al
Aug 6, 2026
NEUTRAL8-K5/10
Vireo Growth Inc. (VREOF) entered into a definitive merger agreement to acquire Planet 13 Holdings I
Jul 30, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 3, 2026
ftd
FTD: VREOF — 69,984 shares ($0.8M) failed to deliver
Settlement: 20260903, Price: $10.80, FTD Value: $755,827.2, VIREO GROWTH INC SUB VTG SHS (
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.36 | $0.36–$0.36 | 279.1% | +0.0% | 0↑ 1↓ | $0.2B | 1 |
| Next Q | $0.39 | $0.39–$0.39 | 221.5% | +4.0% | 0↑ 1↓ | $0.2B | 1 |
| Current FY | $0.05 | $0.05–$0.05 | 102.9% | -75.0% | 0↑ 1↓ | $0.8B | 1 |
| Next FY | $1.94 | $1.94–$1.94 | 3780.0% | +28.5% | 0↑ 1↓ | $1.1B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.360 | — |
| 7d ago | $0.440 | -0.080 |
| 30d ago | $0.360 | — |
| 60d ago | $0.450 | -0.090 |
| 90d ago | $0.450 | -0.090 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
4 insiders, 15 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 15, 2026 | Hussey Ross Michael | Director | AWARD | 115,506 | — | — |
| May 15, 2026 | Hussey Ross Michael | Director | AWARD | 96,859 | — | — |
| May 15, 2026 | Mancebo Victor E. | Director | AWARD | 96,859 | — | — |
| May 15, 2026 | Mancebo Victor E. | Director | AWARD | 115,506 | — | — |
| May 15, 2026 | Apfelbaum Sean Michael | GC and Corporate Secretary | EXERCISE | 133,333 | — | — |
| May 15, 2026 | Apfelbaum Sean Michael | GC and Corporate Secretary | TAX W/H | 39,067 | $0.3850 | $15.0K |
| May 15, 2026 | Apfelbaum Sean Michael | GC and Corporate Secretary | AWARD | 133,333 | — | — |
| May 15, 2026 | Nordquist Judd Theodore | Director | AWARD | 115,506 | — | — |
| May 15, 2026 | Nordquist Judd Theodore | Director | AWARD | 96,859 | — | — |
| May 15, 2026 | Nordquist Judd Theodore | Director | AWARD | 80,000 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for VREOF.
Shares short
34,233
Settlement Sep 15, 2026
Change vs prior
+462.1%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
All VREOF filing & press-release reports (13)
- 8-K reportAug 18, 2026
- 8-K reportAug 11, 2026
- 8-K reportAug 6, 2026
- 8-K reportJul 30, 2026
- 8-K reportJul 27, 2026
- 8-K reportJun 19, 2026
- 8-K reportJun 11, 2026
- 8-K reportJun 9, 2026
- 8-K reportMay 29, 2026
- 8-K reportMay 12, 2026
- S-3 reportApr 23, 2026
- 8-K reportApr 14, 2026
- 8-K reportApr 6, 2026